Clinical Trial

Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study

Name: Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study — clinical trial record (NCT06312722)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PEAK

Recruiting

View on ClinicalTrials.gov →

Summary

The goal of this clinical trial is to verify the continued safety and effectiveness for the Optilume BPH Catheter System.

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2024-03-08; most recent amendment 2026-07-08.

Trial Details

NCT Number	NCT06312722
Lead Sponsor	Urotronic Inc.
Conditions	Benign Prostatic Hyperplasia
Enrollment	92 participants
Start Date	2024-02-07
Primary Completion	2031-02-07 (estimated)
Study Completion	2031-02-07 (estimated)
Updated on ClinicalTrials.gov	2026-07-10